Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New pathway aims to catch silent liver disease in veterans

NCT ID NCT06671886

First seen Nov 16, 2025 · Last updated May 24, 2026 · Updated 23 times

Summary

This study tests a new care pathway designed to help primary care doctors at VA clinics better identify and treat Veterans with non-alcoholic fatty liver disease (NAFLD), a common but often undiagnosed liver condition linked to obesity and diabetes. The pathway automatically flags at-risk patients and educates providers on best practices. Researchers will compare this approach to usual care in 32 primary care teams to see if it increases diagnosis rates and referrals to specialists.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MASLD are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Michael E. DeBakey VA Medical Center, Houston, TX

    RECRUITING

    Houston, Texas, 77030-4211, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.